3-substituted-2-oxindole derivatives
AssigneePfizer Inc.
InventorsFrederick J. Ehrgott, Carl J. Goddard, Gary R. Schulte
Life of this patent
Estimating the term…
Loading patent…
AssigneePfizer Inc.
InventorsFrederick J. Ehrgott, Carl J. Goddard, Gary R. Schulte
Estimating the term…
This invention relates to novel 3-substituted-2-oxindole derivatives which are inhibitors of prostaglandin H.sub.2 synthase, 5-lipoxygenase and interleukin-1 biosynthesis. The compounds of the invention are useful as inhibitors of prostaglandin H.sub.2 synthase and interleukin-1 biosynthesis, per se, and as analgesic, antiinflammatory and antiarthritic agents in the treatment of chronic inflammatory diseases This invention also relates to pharmaceutical compositions comprising said 3-substituted-2-oxindole derivatives; to methods of inhibiting prostaglandin H.sub.2 synthase and biosynthesis of interleukin-1; and to treating chronic inflammatory diseases in a mammal with said compounds. Further, this invention relates to certain novel carboxylic acids useful as intermediates in the preparation of the 3-substituted-2-oxindole derivatives of this invention and to a process for the preparation of the 3-substituted-2-oxindole derivatives.
A compound of the formula ##STR29## and the pharmaceutically-acceptable salts thereof, wherein X is H, F, Cl, Br, (C.sub.1 -C.sub.6)alkyl, (C.sub.3 -C.sub.8)cycloalkyl, NO.sub.2, CF.sub.3, CN, SH, S(O).sub.m R.sup.3, OR.sup.4, COR.sup.4 or CONR.sup.4 R.sup.5 ;
A compound according to claim 11 wherein R.sup.1 Y are each H, F, Cl, NO.sub.2, (C.sub.1 -C.sub.3)alkyl or CF.sub.3.
A compound according to claim 589 wherein R.sup.6 is C.sub.3 ;
Dependencies are inferred from the claim text.